Pertuzumab Side Effects
Medically reviewed by Drugs.com. Last updated on Mar 9, 2024.
Applies to pertuzumab: intravenous solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (solution)
Pertuzumab can result in subclinical and clinical cardiac failure manifesting as decreased left ventricular ejection fraction and congestive heart failure.
Evaluate cardiac function prior to and during treatment.
Discontinue pertuzumab treatment for a confirmed clinically significant decrease in left ventricular function.
Exposure to pertuzumab can result in embryo-fetal death and birth defects.
Advise patients of these risks and the need for effective contraception.
Serious side effects of pertuzumab
Along with its needed effects, pertuzumab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking pertuzumab:
More common side effects
- black, tarry stools
- burning, numbness, tingling, or painful sensations
- chills
- cough
- fast heartbeat
- fever
- hives, itching, or rash
- hoarseness
- joint pain, stiffness, or swelling
- lower back or side pain
- painful or difficult urination
- pale skin
- redness of the skin
- sore throat
- swelling of the eyelids, face, lips, hands, or feet
- tightness in the chest
- troubled breathing or swallowing
- ulcers, sores, or white spots in the mouth
- unsteadiness or awkwardness
- unusual bleeding or bruising
- unusual tiredness or weakness
- weakness in the arms, hands, legs, or feet
Other side effects of pertuzumab
Some side effects of pertuzumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- body aches or pain
- change in taste
- cracked lips
- decreased appetite
- diarrhea
- dizziness
- dry skin
- ear congestion
- hair loss or thinning of the hair
- headache
- loosening of the fingernails
- loss of taste
- loss of voice
- nasal congestion
- nausea
- redness or soreness around the fingernails
- runny nose
- sneezing
- vomiting
- watering of the eyes
For healthcare professionals
Applies to pertuzumab: intravenous solution.
Cardiovascular adverse events
- Common (1% to 10%): Left ventricular dysfunction (including congestive heart failure)[Ref]
Dermatologic
- Very common (10% or more): Alopecia (61%), rash (34%), nail disorder (23%), pruritus (14%)
- Common (1% to 10%): Dry skin, palmar-plantar erythrodysesthesia syndrome[Ref]
Gastrointestinal
- Very common (10% or more): Diarrhea (67%), nausea (42%), mucositis/mucosal inflammation (28%), constipation (25%), vomiting (24%), stomatitis (19%), dyspepsia (12%)[Ref]
Hematologic
- Very common (10% or more): Neutropenia (53%), anemia (23%), leucopenia (20%), febrile neutropenia (13%)[Ref]
Hypersensitivity
- Very common (10% or more): Hypersensitivity/anaphylactic reaction, infusion reaction/cytokine release syndrome[Ref]
Metabolic
- Very common (10% or more): Decreased appetite (29%)[Ref]
Musculoskeletal
- Very common (10% or more): Myalgia (24%), arthralgia (15%), pain in extremity (15%)[Ref]
Nervous system
- Very common (10% or more): Peripheral neuropathy (21%), headache (21%), dysgeusia (18%), peripheral sensory neuropathy (14%), dizziness (13%)[Ref]
Ocular
- Very common (10% or more): Increased lacrimation (14%)[Ref]
Psychiatric
Respiratory
- Very common (10% or more): Cough (21%), upper respiratory tract infection (17%), dyspnea (16%), nasopharyngitis (13%)
- Common (1% to 10%): Paronychia, pleural effusion, epistaxis
- Uncommon (0.1% to 1%): Interstitial lung disease[Ref]
Other
- Very common (10% or more): Fatigue (38%), peripheral edema (30%), asthenia (30%), pyrexia (19%), pain
- Common (1% to 10%): Chills[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. Cerner Multum, Inc. "Australian Product Information."
3. (2012) "Product Information. Perjeta (pertuzumab)." Genentech
Frequently asked questions
- How long can you stay on Herceptin and Perjeta?
- How much does Perjeta cost?
- Is Perjeta a chemotherapy drug?
- How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?
More about pertuzumab
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Pertuzumab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.